Enveric Biosciences, Inc.
4851 Tamiami Trail N, Suite 200
Naples, FL 34103
July 8, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Jennifer Angelini
Re: | Enveric Biosciences, Inc. |
Registration Statement on Form S-3
Filed on July 2, 2021
File No. 333-257690 (the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Enveric Biosciences, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 5:00 p.m., Eastern Time, on July 9, 2021, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Rick A. Werner, Esq. at (212) 659-4974.
Very truly yours, | ||
ENVERIC BIOSCIENCES, INC. | ||
By: | /s/ David Ian Johnson | |
David Ian Johnson | ||
Chief Executive Officer and Chairman of the Board of Directors |
cc: | Rick A. Werner, Esq., Haynes and Boone, LLP |